Cisplatin Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Cisplatin Manufacturers of Cisplatin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Cisplatin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 50 to 70 mg/sq.meter60 (60)As recommended.IVadvanced bladder cancer once every 3 to 4 weeks.75 to 100 mg/sq.meter88 (87.5)As recommended.IVOnce every 4 weeks metastatic ovarian tumors.15 to 20 mg/ sq.meter/day18 (17.5)As recommended.IV InfFor 5 days every month, As Required. Metastatic testicular tumors. Paedriatic Dosage (20kg) 32 to 17.5 mg/sq.meter25 (24.75)24 hourly15 to 20 mg/sq.meter18 (17.5)24 hourlyIntra VenousFor 5 Days, every 3-4 Weeks Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Cisplatin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Cisplatin Back to top Manufacturers of Cisplatin in Pakistan A.J.Mirza Al-Habib Atco Bio Pharma CCL Highnoon Neo Pfizer Pharmedic Pliva S.Ejazuddin Scharper Turner Umair Back to top Previous Drug Generic - Next Drug Generic